Mapping metabolic and lipid changes in Alzheimer's brains

Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain

NIH-funded research Johns Hopkins University · NIH-11091658

Researchers are using advanced imaging that shows chemicals and fats in brain tissue from people with Alzheimer's to pinpoint changes linked to inflammation and cell damage.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11091658 on NIH RePORTER

What this research studies

If you or a loved one has Alzheimer's, this project will use imaging mass spectrometry to make detailed maps of metabolites and lipids in donated brain tissue, showing where chemical changes occur. The team focuses on how immune cells (microglia) and support cells (astrocytes) switch to inflammatory, neurotoxic states and how that ties to shifts in energy use and lipid release from APOE/APOJ. They compare affected and unaffected brain regions to find patterns that may explain why neurons die and to identify potential biomarkers. The work pairs human tissue mapping with laboratory models to link the chemical maps to specific cellular mechanisms.

Who could benefit from this research

Good fit: Ideal participants are people with Alzheimer's (or their families) who can donate brain tissue after death or enroll in related tissue-collection or observational components.

Not a fit: People without Alzheimer's or those seeking immediate treatment changes are unlikely to receive direct medical benefit from this basic tissue-mapping project.

Why it matters

Potential benefit: If successful, this could reveal chemical markers or pathways to guide new tests or treatments that protect brain cells in Alzheimer's.

How similar studies have performed: Prior work has shown microglia-driven reactive astrocytes can harm neurons and early imaging mass spectrometry studies have mapped some chemical changes in Alzheimer's tissue, but combining large-scale metabolomic imaging with lipid and cell-type analysis is relatively new.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.